Skip to content
Lower risk Drug recall · FDA · Published August 13, 2026

Apotex Paxil CR 37.5mg Tablets Recall: Failed Stability Testing

Apotex recalls 37.5mg Paxil CR tablets due to failing 24-month stability tests. This may affect medication safety. Check your prescription bottle for NDC 60505-4379-3.

🇺🇸 FDA recall #D-0804-2026DrugApotex ›
✎ GovInfoNow plain-language explainer

Apotex is recalling Paxil CR 37.5mg extended-release tablets because they failed stability testing. This means the medication might not be safe after 24 months. People with prescriptions for this drug should check their bottles. Read more at govinfonow.com/recall/692847-apotex-paxil-cr-37-5mg-tablets-recall-failed-stability-testing.

Source Summary by GovInfoNow · govinfonow.com/recall/692847-apotex-paxil-cr-37-5mg-tablets-recall-failed-stability-testing · Updated September 14, 2026 · FDA enforcement record: FDA #D-0804-2026

Cite this page

“Apotex Paxil CR 37.5mg Tablets Recall: Failed Stability Testing.” GovInfoNow, updated September 14, 2026. https://govinfonow.com/recall/692847-apotex-paxil-cr-37-5mg-tablets-recall-failed-stability-testing. Based on FDA recall #D-0804-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0804-2026%22&limit=1).

Apotex Corp. voluntarily recalled Paxil CR and Paroxetine Extended-Release Tablets due to failed dissolution specifications, the Food and Drug Administration said on Aug. 13, 2026. The Class II recall affects 6,972 bottles distributed nationwide.

How to tell if you have it

  • Brand: Apotex
  • Product: Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle
  • NDC: 60505-4379-3
  • Lot #: TY9494
  • Exp Date: 05/31/2027

The hazard

The product failed to meet 24-month stability testing acceptance criteria, according to the FDA. The recall is classified as Class II.

Context

GovInfoNow's records show Apotex Corp. has 23 other recalls on record since June 14, 2007. Other recent recalls of similar products include Apotex Desmopressin Nasal Spray Recall (April 8, 2026), Apotex Brimonidine/Timolol Eye Drops Recall (March 5, 2026), and Apotex Brimonidine/Timolol Eye Drops Recall (Sept. 5, 2025). Other recent recalls of similar products include Safecor Health Fluphenazine Elixir Recall (Aug. 13, 2026), Mylan Prasugrel Tablets Recall (Aug. 17, 2026), and Cipla Phytonadione Injectable Emulsion Recall (Oct. 31, 2025).

How to tell if you have this one

Check for the NDC code 60505-4379-3 on the bottle. Look for the lot number TY9494 and expiration date 05/31/2027.

  • Brand
    Apotex
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Medication

    Look for the NDC code 60505-4379-3 on the bottle label.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 20 days after the firm started it.

1. Firm started the recall: Aug 13, 202612. FDA classified it Class II: Aug 27, 202623. Published in FDA’s Enforcement Report: Sep 2, 202634. Added to GovInfoNow: Sep 8, 202642026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Apotex recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0804-2026 (August 13, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0804-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on September 14, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA